Tag Archives: Xarelto
Zadroga Act Cancer Decision Expected This Week
The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...
What Action Will the FDA Take on E-cigarettes?
As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.
Knee Replacement Patients Should Consider Nickel Allergies before Surgery
Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...
Smokers More Vulnerable to Joint Replacement Failures
People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.
J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination
J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.
Former Executives Accuse Health Technology Firm of Fraud
Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.
Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...
Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices
Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.
FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety
An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...
FDA Gives 7 Companies Go Ahead To Market Generic Plavix
The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...Xarelto Manufacturer Leads Spending for Physicians’ Favor
The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, … Continue reading
Pretrial Proceedings Moving Forward in First Four Xarelto Bellwether Cases
In a recent court order, Judge Eldon Fallon, who oversees the Xarelto multidistrict litigation in the Eastern District of Louisiana, outlined the schedule for the first four trials. Judge Fallon has selected four cases to serve as the first bellwether … Continue reading
Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement
The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading
Xarelto Plaintiffs have More Time to File Lawsuits
Due to the number of Xarelto lawsuits that have flooded the clerk’s office, Judge Eldon Fallon has extended the filing deadline by 90 days. There are more than 7,000 lawsuits pending in the multidistrict litigation in the Eastern District of … Continue reading
In Xarelto MDL, Judge Extends Deadline to File Complaints
Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in … Continue reading
Quality of Xarelto Clinical Trials Expected to be an Issue in 2017 Court Cases
When the first lawsuits involving the blood-thinning drug Xarelto go to trial in 2017, attorneys expect the quality of the clinical trials involved in the drug’s approval to be a major issue. Xarelto lawsuits have been filed in both federal … Continue reading
Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny
According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner … Continue reading
Bellwether Trial Dates in Xarelto Litigation Scheduled for 2017
Bellwether trial dates have been selected in the Xarelto multidistrict litigation (MDL) 2592. Court records show that more than 2,800 lawsuits have been consolidated into the MDL in Eastern Louisiana before U.S. District Judge Eldon E. Fallon. A list of … Continue reading
Lawsuit Alleges Eliquis Caused Fatal Hemorrhaging, Drug Makers Failed to Warn
Pfizer and Bristol-Myers Squibb are facing a wrongful death lawsuit alleging that the companies failed to warn about the risk of irreversible bleeding with Eliquis (apixaban), an anticoagulant. The lawsuit was filed on behalf of a woman whose husband began … Continue reading
Xarelto Led to Uncontrollable, Fatal Bleeding, Lawsuit Alleges
A woman in Vermont has filed a lawsuit alleging that her father suffered a fatal, uncontrollable brain bleed after taking the anticoagulant Xarelto. The lawsuit alleges that Bayer AG and Janssen Pharmaceuticals failed to warn about the risk of irreversible … Continue reading
